Can slow walking speed in elderly signal Alzheimer's disease hallmarks?

by American Academy of NeurologyDiagram of the brain of a person with Alzheimer's Disease. Credit: Wikipedia/public domain.How fast elderly people walk may be related to the amount of amyloid

Updated on: February 27,2024

Can slow walking speed in elderly signal Alzheimer's disease hallmarks?

by American Academy of NeurologyDiagram of the brain of a person with Alzheimer's Disease. Credit: Wikipedia/public domain.How fast elderly people walk may be related to the amount of amyloid

Updated on:February 27,2024

Chemical clears Alzheimer's protein and restores memory in mice

by Alzheimer's Research UKDiagram of the brain of a person with Alzheimer's Disease. Credit: Wikipedia/public domain.A research team in Korea has tested a chemical in mice genetically alt

Updated on: February 27,2024

Chemical clears Alzheimer's protein and restores memory in mice

by Alzheimer's Research UKDiagram of the brain of a person with Alzheimer's Disease. Credit: Wikipedia/public domain.A research team in Korea has tested a chemical in mice genetically alt

Updated on:February 27,2024

How molecules in the zebrafish brain indicate it's time to quit a fight

byRIKENCredit:Current Biology(2023). DOI: 10.1016/j.cub.2023.03.087Two RIKEN neuroscientists have uncovered a molecular switch in the zebrafish brain that causes a fish to quit fight

Updated on: January 12,2024

How molecules in the zebrafish brain indicate it's time to quit a fight

byRIKENCredit:Current Biology(2023). DOI: 10.1016/j.cub.2023.03.087Two RIKEN neuroscientists have uncovered a molecular switch in the zebrafish brain that causes a fish to quit fight

Updated on:January 12,2024

New clues to early development of schizophrenia

byElsevierDerivation and characterization of hCSs. (A) Experimental design of the study. (B) Main growth factors and media used for neural induction and differentiation. DM and SB are SMAD inhib

Updated on: January 12,2024

New clues to early development of schizophrenia

byElsevierDerivation and characterization of hCSs. (A) Experimental design of the study. (B) Main growth factors and media used for neural induction and differentiation. DM and SB are SMAD inhib

Updated on:January 12,2024

Gene ID'd as potential therapeutic target for dementia in Parkinson's

by Washington University School of MedicineClumps of the Parkinson's protein alpha-synuclein (red) are visible inside neurons (green) in the brain of a mouse. Researchers at Washington Univer

Updated on: June 14,2024

Gene ID'd as potential therapeutic target for dementia in Parkinson's

by Washington University School of MedicineClumps of the Parkinson's protein alpha-synuclein (red) are visible inside neurons (green) in the brain of a mouse. Researchers at Washington Univer

Updated on:June 14,2024

AI reveals new insights into human brain activity

byFriedrich–Alexander University Erlangen–NurnbergTuning curve: a: LFP stream of 3 electrodes (shades of blue) during 50 ms pure tone stimuli (pure tone intensity: 110 dB SPL−70 dB SPL, frequenc

Updated on: September 23,2024

AI reveals new insights into human brain activity

byFriedrich–Alexander University Erlangen–NurnbergTuning curve: a: LFP stream of 3 electrodes (shades of blue) during 50 ms pure tone stimuli (pure tone intensity: 110 dB SPL−70 dB SPL, frequenc

Updated on:September 23,2024

Dementia and self-harm: Why it's crucial to support patients in first year after diagnosis

by Lachlan Gilbert,University of New South WalesCredit: AI-generated imagePeople diagnosed with dementia are more likely to self-harm within the first six to 12 months after initial diagnosis, h

Updated on: May 08,2024

Dementia and self-harm: Why it's crucial to support patients in first year after diagnosis

by Lachlan Gilbert,University of New South WalesCredit: AI-generated imagePeople diagnosed with dementia are more likely to self-harm within the first six to 12 months after initial diagnosis, h

Updated on:May 08,2024

Antibody therapy inspired by patient case reduces tau tangles in a preclinical model of Alzheimer's disease

by Mass General BrighamCredit: Pixabay/Pete Linforth.A team led by researchers from Mass General Brigham reports promising results for a monoclonal antibody that takes aim at a new target for Alz

Updated on: March 02,2024

Antibody therapy inspired by patient case reduces tau tangles in a preclinical model of Alzheimer's disease

by Mass General BrighamCredit: Pixabay/Pete Linforth.A team led by researchers from Mass General Brigham reports promising results for a monoclonal antibody that takes aim at a new target for Alz

Updated on:March 02,2024

Researchers develop new brain network modeling tools to advance Alzheimer's disease research

by Indiana University School of MedicineCredit: CC0 Public DomainIndiana University researchers are collaborating on a novel approach to use neuroimaging and network modeling tools—previously dev

Updated on: February 24,2024

Researchers develop new brain network modeling tools to advance Alzheimer's disease research

by Indiana University School of MedicineCredit: CC0 Public DomainIndiana University researchers are collaborating on a novel approach to use neuroimaging and network modeling tools—previously dev

Updated on:February 24,2024

Moving beyond memory metrics for early identification of Alzheimer's risk

by Cognitive Neuroscience SocietyCredit: Pixabay/CC0 Public DomainSay the words "Alzheimer's disease," and the next word that most readily comes to mind is likely "memory.&quot

Updated on: February 03,2024

Moving beyond memory metrics for early identification of Alzheimer's risk

by Cognitive Neuroscience SocietyCredit: Pixabay/CC0 Public DomainSay the words "Alzheimer's disease," and the next word that most readily comes to mind is likely "memory.&quot

Updated on:February 03,2024

Insurers balk at paying for Biogen's $56,000-a-year Alzheimer's treatment

by John Tozzi, Angelica Lavito and Anushree DaveCredit: CC0 Public DomainU.S. health insurers say they want more proof before paying for Biogen Inc.'s Aduhelm, stalling sales of the costly new Alz

Updated on: April 29,2024

Insurers balk at paying for Biogen's $56,000-a-year Alzheimer's treatment

by John Tozzi, Angelica Lavito and Anushree DaveCredit: CC0 Public DomainU.S. health insurers say they want more proof before paying for Biogen Inc.'s Aduhelm, stalling sales of the costly new Alz

Updated on:April 29,2024

Special properties of pneumococci affect their ability to cause meningitis

by Karolinska InstitutetCredit: AI-generated imageStructures on the surface of pneumococci determine the ability of these bacteria to enter the brain and cause severe infections, according to a p

Updated on: March 06,2024

Special properties of pneumococci affect their ability to cause meningitis

by Karolinska InstitutetCredit: AI-generated imageStructures on the surface of pneumococci determine the ability of these bacteria to enter the brain and cause severe infections, according to a p

Updated on:March 06,2024